Sehreen A

Sehreen A. has a diverse work experience in the medical field. Sehreen began their career as a Clinical Laboratory Scientist in Flow Cytometry at MD Anderson Cancer Center in December 2013. Sehreen held this position until October 2020, during which they also served as a Molecular Laboratory Scientist in the COVID-19 Diagnostic Testing Lab from April to August 2020.

In November 2019, Sehreen joined Aga Khan University Hospital as a Flow Cytometry Specialist, a role they held until February 2020. Sehreen then moved on to work at UTHealth Program of Regenerative Medicine as a Quality Improvement Coordinator and Flow Cytometry Specialist from November 2020 to October 2022.

Sehreen also contributed to the fight against COVID-19 as a Molecular Diagnostic Laboratory Consultant at Aga Khan Medical Center Gilgit-Baltistan from November to December 2021.

Most recently, in October 2022, Sehreen joined Affini-T Therapeutics as a Scientist.

Sehreen A.'s education history includes attending The University of Texas Medical Branch. However, no specific information is provided regarding the years attended, degree obtained, or field of study.